F-18 FDG PET/CT代谢肿瘤体积预测播散性上皮性卵巢癌患者的总生存期
研究纳入31例上皮性卵巢癌腹膜癌患者,在减瘤术后早期再分期时行[F-18]FDG PET/CT,测量残留腹膜病灶的SUVmax、MTV(42%阈值)和TLG,随访20±12个月并与总生存期比较。SUVmax对总生存期无显著差异(p=0.48);MTV较高者总生存期显著高于较低者(p=0.01;26 vs. 14个月),TLG呈相似趋势但未达显著(p=0.06)。作者认为MTV定量评估可能有助于对腹膜癌患者进行分层以实施合适治疗方案。
要点
- MTV较高者总生存期显著高于较低者(p=0.01;26 vs. 14个月)。
- SUVmax对总生存期无显著差异(p=0.48)。
- TLG呈相似趋势但未达统计学显著(p=0.06)。
核心结论
- PET/CT的MTV定量评估而非SUVmax和TLG可能有助于对上皮性卵巢癌腹膜癌患者进行分层,以实施合适的治疗方案。
研究设计与样本
- 研究纳入31例上皮性卵巢癌患者,在减瘤术后早期再分期时行PET/CT,患者此前已诊断为腹膜癌(化疗前);在残留腹膜病灶上记录SUVmax、MTV(cm3;42%阈值)和TLG(g);随访20±12个月;将PET/CT结果与总生存期比较。
诊断标准与关键数值
- MTV以42%阈值测量,单位为cm3。
- TLG单位为g。
- SUVmax的Kaplan-Meier生存分析未显示总生存期显著差异(p=0.48)。
- MTV生存分析显示肿瘤负荷较高者总生存期显著高于肿瘤负荷较低者(p=0.01;26 vs. 14个月)。
- TLG呈相似趋势但未达统计学显著(p=0.06)。
临床应用与阅片要点
- 作者认为,除化疗耐药外,MTV越高对化疗的反应越好。
- 作者认为MTV定量评估可能有助于对上皮性卵巢癌腹膜癌患者进行分层以实施合适治疗方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We evaluated the prognostic impact of quantitative assessment by maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV) and tumour lesion glycolysis (TLG) on [F-18] FDG PET/CT for patients with peritoneal carcinomatosis from epithelial ovarian cancer (EOC).
METHODS: Thirty-one patients with EOC underwent PET/CT for an early restaging after cytoreductive surgery, having been diagnosed with carcinomatosis (before chemotherapy). The SUVmax, MTV (cm3; 42% threshold) and TLG (g) were registered on residual peritoneal lesions. The patients were followed up 20±12months thereafter. The PET/CT results were compared to overall survival (OS).
RESULTS: The Kaplan-Meier survival analysis for the SUVmax did not reveal significant differences in OS (p=0.48). The MTV survival analysis showed a significant higher OS in patients presenting with a higher tumour burden than those with less tumour burden (p=0.01; 26 vs. 14 months), whereas TLG exhibited a similar trend though not significant (p=0.06). Apart from chemo-resistance, the higher the MTV, the better will be the response to chemotherapy.
CONCLUSIONS: Quantitative assessment by MTV rather than by SUVmax and TLG on PET/CT may be helpful for stratifying patients who present with peritoneal carcinomatosis from EOC, in order to implement the appropriate therapeutic regimen.
引用
- Gallicchio R, Nardelli A, Venetucci A, et al. F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer. Eur J Radiol. 2017. PMID: 28668403. doi:10.1016/j.ejrad.2017.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。